Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.13 Analyst target: $7.20 Upside: 537.17%
Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is headquartered in Bethesda, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.